Lyell Immunopharma, Inc.
LYEL
$13.95
$0.211.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 204.10M | 254.02M | 247.22M | 319.62M | 276.79M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.44M | 13.28M | 13.72M | 8.58M | 5.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 213.54M | 267.30M | 260.94M | 328.20M | 282.21M |
|
|
|||||
| Total Current Assets | 213.54M | 267.30M | 260.94M | 328.20M | 282.21M |
| Net Property, Plant & Equipment | 47.29M | 50.55M | 53.64M | 56.63M | 60.07M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.43M | 6.82M | 6.47M | 4.13M | 4.11M |
| Total Assets | 311.15M | 350.63M | 340.05M | 407.97M | 385.45M |
|
|
|||||
| Total Accounts Payable | 3.88M | 5.47M | 2.89M | 2.57M | 3.38M |
| Total Accrued Expenses | 25.82M | 21.22M | 20.94M | 20.52M | 19.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.66M | 9.36M | 9.07M | 8.79M | 8.51M |
| Total Finance Division Other Current Liabilities | 500.00K | 900.00K | 16.51M | -- | 5.53M |
| Total Other Current Liabilities | 500.00K | 900.00K | 16.51M | -- | 5.53M |
| Total Current Liabilities | 39.87M | 36.95M | 49.41M | 31.88M | 36.90M |
|
|
|||||
| Total Current Liabilities | 39.87M | 36.95M | 49.41M | 31.88M | 36.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 36.93M | 39.49M | 41.92M | 44.29M | 46.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 537.00K | 527.00K | 517.00K | 2.68M | 3.03M |
| Total Liabilities | 77.34M | 76.96M | 91.85M | 78.84M | 86.53M |
|
|
|||||
| Common Stock & APIC | 1.92B | 1.92B | 1.87B | 1.81B | 1.74B |
| Retained Earnings | -1.69B | -1.64B | -1.62B | -1.48B | -1.44B |
| Treasury Stock & Other | -158.00K | -9.00K | 242.00K | 201.00K | 57.00K |
| Total Common Equity | 233.82M | 273.67M | 248.20M | 329.12M | 298.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 233.82M | 273.67M | 248.20M | 329.12M | 298.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 233.82M | 273.67M | 248.20M | 329.12M | 298.92M |
|
|
|||||